Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Long-Term Deferred Tax (2022)

Historic Long-Term Deferred Tax for Therapeutics (LENZ) over the last 1 years, with Q4 2022 value amounting to $39.3 million.

  • Therapeutics' Long-Term Deferred Tax changed N/A to $39.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $39.3 million, marking a year-over-year change of. This contributed to the annual value of $39.3 million for FY2022, which is N/A changed from last year.
  • Therapeutics' Long-Term Deferred Tax amounted to $39.3 million in Q4 2022.
  • Therapeutics' Long-Term Deferred Tax's 5-year high stood at $39.3 million during Q4 2022, with a 5-year trough of $39.3 million in Q4 2022.